Daniel H Mathers, MD | |
988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 | |
(402) 559-8888 | |
(402) 559-3060 |
Full Name | Daniel H Mathers |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 55 Years |
Location | 988102 Nebraska Medical Ctr, Omaha, Nebraska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295784221 | NPI | - | NPPES |
47078557520 | Medicaid | NE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 12422 (Nebraska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The Nebraska Medical Center | Omaha, NE | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Unmc Physicians | 6002728391 | 1320 |
News Archive
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.
Naloxone has saved thousands of lives. But can patients be safely discharged from the Emergency Department (ED) just an hour after they receive the medication that curtails drug overdoses?
National Institutes of Health scientists have filled a research gap by developing a laboratory model to study ticks that transmit flaviviruses, such as Powassan virus. Powassan virus was implicated in the death of a New York man earlier this year.
Two-thirds of HIV-positive pregnant women in the developing world do not have access to treatment to prevent mother-to-child HIV transmission, which could lead to 370,000 new HIV cases annually among infants, according to a study released Thursday by the International Treatment Preparedness Coalition, Bloomberg reports (Chase, Bloomberg, 5/21).
› Verified 5 days ago
Entity Name | Unmc Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.
Naloxone has saved thousands of lives. But can patients be safely discharged from the Emergency Department (ED) just an hour after they receive the medication that curtails drug overdoses?
National Institutes of Health scientists have filled a research gap by developing a laboratory model to study ticks that transmit flaviviruses, such as Powassan virus. Powassan virus was implicated in the death of a New York man earlier this year.
Two-thirds of HIV-positive pregnant women in the developing world do not have access to treatment to prevent mother-to-child HIV transmission, which could lead to 370,000 new HIV cases annually among infants, according to a study released Thursday by the International Treatment Preparedness Coalition, Bloomberg reports (Chase, Bloomberg, 5/21).
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Daniel H Mathers, MD 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: (402) 559-8888 | Daniel H Mathers, MD 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: (402) 559-8888 |
News Archive
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.
Naloxone has saved thousands of lives. But can patients be safely discharged from the Emergency Department (ED) just an hour after they receive the medication that curtails drug overdoses?
National Institutes of Health scientists have filled a research gap by developing a laboratory model to study ticks that transmit flaviviruses, such as Powassan virus. Powassan virus was implicated in the death of a New York man earlier this year.
Two-thirds of HIV-positive pregnant women in the developing world do not have access to treatment to prevent mother-to-child HIV transmission, which could lead to 370,000 new HIV cases annually among infants, according to a study released Thursday by the International Treatment Preparedness Coalition, Bloomberg reports (Chase, Bloomberg, 5/21).
› Verified 5 days ago
Dr. Marium Ilahi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7710 Mercy Rd, Suite 426, Omaha, NE 68124 Phone: 402-717-3636 Fax: 402-717-5050 | |
Dr. Vidhya Murukesan, M.B.,B.S Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St, Creighton University - Gme, Omaha, NE 68131 Phone: 402-280-5250 | |
Matthew John Kapalis, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 402-398-6255 Fax: 402-398-6255 | |
Abbie K Ray-deering, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 17500 Burke St, Omaha, NE 68118 Phone: 402-354-2360 Fax: 402-354-2440 | |
Dr. Elizabeth Rini Schnaubelt, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-5581 | |
Sarah Kesterson, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 982055 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7792 Fax: 402-559-9385 | |
Dr. Lauren C Licitra, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 42 Nd And Emile St, Omaha, NE 68198 Phone: 402-559-4000 |